Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McFadyen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel and potent cyclic cyanamide-based cathepsin K inhibitorsDavid N Deaton, Anne M Hassell, Robert B McFadyen, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
A structural screening approach to ketoamide-based inhibitors of cathepsin KDavid G Barrett, John G Catalano, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Exploration of the P1 SAR of aldehyde cathepsin K inhibitorsJohn G Catalano, David N Deaton, Eric S Furfine, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2005
Acyclic cyanamide-based inhibitors of cathepsin KDavid G Barrett, David N Deaton, Anne M Hassell, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitorsEric E Boros, David N Deaton, Anne M Hassell, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064Jonathan Y Bass, Richard D Caldwell, Justin A Caravella, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?Kim K Adkison, David G Barrett, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthaleneJonathan Y Bass, Justin A Caravella, Lihong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2009
FXR agonist activity of conformationally constrained analogs of GW 4064Adwoa Akwabi-Ameyaw, Jonathan Y Bass, Richard D Caldwell, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel and potent cyclic cyanamide-based cathepsin K inhibitorsDavid N Deaton, Anne M Hassell, Robert B McFadyen, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
A structural screening approach to ketoamide-based inhibitors of cathepsin KDavid G Barrett, John G Catalano, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Exploration of the P1 SAR of aldehyde cathepsin K inhibitorsJohn G Catalano, David N Deaton, Eric S Furfine, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2005
Acyclic cyanamide-based inhibitors of cathepsin KDavid G Barrett, David N Deaton, Anne M Hassell, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitorsEric E Boros, David N Deaton, Anne M Hassell, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064Jonathan Y Bass, Richard D Caldwell, Justin A Caravella, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?Kim K Adkison, David G Barrett, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthaleneJonathan Y Bass, Justin A Caravella, Lihong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2009
FXR agonist activity of conformationally constrained analogs of GW 4064Adwoa Akwabi-Ameyaw, Jonathan Y Bass, Richard D Caldwell, et al.
Pageof 3